SecBot SecBot

BLCO

Bausch & Lomb Corp
NYSE· Ophthalmic Goods· CIK 0001860742 Healthcare & Medical Devices
$20.88 −0.21 (−1.00%)
Nov 16 4:00 PM ET · prev $21.09
Market cap
$7.6B
Mid cap
Consensus
Buy
58% Buy or better · 19 analysts
Median target
$22.00
+5% · range $18.00–26.00
1 year
+39.2%
from $15.00 · Nov 17
30 days
+25.7%
from $16.61
52-week range
$14.56–21.37
−2% from high · low Nov 20
Avg volume 20D
1.06M
Oct 28 spike 4.11M
Short interest
2.59M
≈0.7% of shares · +1.9%
Days to cover
2.3
at average volume
Insider net
−$2.8M
4 buyers · 2 sellers · since Mar 2
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
24
analyzed by SecBot
SecBot read BULLISH 8 reports · 90 days
Balance 0 bearish · 2 bullish · 1 mixed · 5 neutral oldest → newest, height = score
Avg score ·High conf. 7/8

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    4 insiders bought $650.4K at an average $17.21. 2 insiders sold $3.5M. Price is 21% above their cost.

  • InstitutionsMIXED

    Q3 2026: 6 added (0 new), 8 trimmed or exited.

  • AnalystsBULLISH

    11 of 19 rate it Buy or better. Median target $22.00 (+5%).

  • Short sellersSTEADY

    Short interest +1.9% to 2.59M shares. 2.3 days to cover, ≈0.7% of shares.

  • TrendUPTREND

    16% above its 50-day average. New closing high $21.37 on Nov 10.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
ICAHN CARL CTRIM2,378,100$40.4M
UBS Group AGTRIM333,830$5.7M
JPMORGAN CHASE & CODOUBLED298,670$5.1M
BNP PARIBAS FINANCIAL MARKETSADD239,593$4.1M
Jump Financial, LLCNEAR_EXIT19,300$328.1K
SIMPLEX TRADING, LLCNEAR_EXIT1,139$19.4K
PRICE T ROWE ASSOCIATES INC /MD/ADD2,161,232$35.8M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPADD1,364,980$22.6M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

19 analysts
Buy 58% rate it Buy or better
Strong Buy4Buy7Hold7Sell1Strong Sell0
12-month targets · 14 analysts

Price is inside the target range. Median implies +5%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 2, 2026HC Wainwright & Co.
DOWNGRADE
DOWNGRADENeutral
Oct 29, 2026JP Morgan
MAINTAIN
MAINTAINNeutral
Oct 29, 2026Citigroup
MAINTAIN
MAINTAINBuy
Oct 29, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Oct 29, 2026Wells Fargo
MAINTAIN
MAINTAINEqual-Weight
Oct 7, 2026Barclays
INITIATE
INITIATEOverweight

Insider ledger

Form 4
$650.4K
bought · 4 insiders
$3.5M
sold · 2 insiders
+21.4%
vs their $17.21 cost
DateInsiderTypeValue
Oct 29, 2026
Alfonso Eduardo
Director
Oct 29, 2026
AWARD$22.9K
Oct 29, 2026
Munsch Frederick
SVP, Controller and CAO
Oct 29, 2026
EXERCISE$1.6M
Oct 29, 2026
Munsch Frederick
SVP, Controller and CAO
Oct 29, 2026
SELL$2.3M
Oct 29, 2026
Munsch Frederick
SVP, Controller and CAO
Oct 29, 2026
EXERCISE$432.9K
Oct 29, 2026
Paulson John
Director
Oct 29, 2026
AWARD$22.9K
Oct 29, 2026
ROBERTSON RUSSEL C
Director
Oct 29, 2026
AWARD$25.6K
Aug 12, 2026
Trebbi Barbara
Director
Aug 12, 2026
AWARD11,776 sh
Aug 12, 2026
Chersi Robert J
Director
Aug 12, 2026
AWARD11,776 sh

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Washington

Corporate Lobbying

3 lobbying filings and 0 bills this company lobbies on, with spend, stage and how each bill touches it, are for subscribers.

Subscribe for Full Access

Short side

FINRA· Oct 30, 2026
2,590,201
shares short
+1.9%
vs prior settlement
2.3
days to cover
≈0.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 12, 2026 SEC
Former director Karen Ling filed a Form 144 notice to sell 12,838 common shares of Bausch & Lomb Corp, valued at…
144 · Impact 2/10
Nov 3, 2026 SEC
Nathalie D. Bernier, a former director of Bausch & Lomb Corp, filed a Form 144 notice of intent to sell 40,022 shares…
144 · Impact 2/10
Oct 29, 2026 SEC
Frederick Munsch, an officer of Bausch & Lomb Corp, filed a Form 144 notice of intent to sell 112,015 shares of common…
144 · Impact 3/10
Oct 29, 2026 Insider
Alfonso Eduardo was granted 1,125 shares
Director @ $20.40 ($22.9K)
Oct 29, 2026 Insider
Munsch Frederick acquired via exercise 87,912 shares
SVP, Controller and CAO @ $18.00 ($1.6M)
Oct 29, 2026 Insider
Munsch Frederick sold 112,015 shares
SVP, Controller and CAO @ $20.48 ($2.3M)
Oct 28, 2026 Earnings result
BLCO Q3 2026 Earnings: EPS $0.34 (+53.4% vs est)
Oct 1, 2026 Event
Gemini Insurance Company v. Bausch & Lomb Americas, Inc.
Court ruling (del), Docket: 127, 2026
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent

SecBot reports

24 filings · 5 bullish · 0 bearish · 2 mixed · 17 neutral
All BLCO filing & press-release reports (24)